177Lu-AB-3PRGD2 in Patients With Integrin αVβ3 Positive Tumors

Clinical trial NCT05013086 · UNKNOWN

Trial details

NCT number: NCT05013086
Sponsor: Peking Union Medical College Hospital
Status: UNKNOWN
Phase: Early Phase 1
Study type: INTERVENTIONAL

Integrin αVβ3 Positive Tumors

Start date: 2021-10-01
Primary completion: 2024-10-30
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.